Xsolis Introduces Generative AI Tool to Expedite Payer Denial Reviews
Event summary
- Xsolis launched its GenAI Peer-to-Peer Clinical Synopsis solution on September 1, 2026, integrated within Dragonfly Advise.
- The tool automates the extraction of key clinical facts from medical records to streamline peer-to-peer reviews following payer denials.
- Pilot results with Beacon Health System showed a 68% reduction in medical necessity review time, from 15 minutes to 4.7 minutes.
- Xsolis has signed agreements with several health system partners for implementation in the coming months.
The big picture
Xsolis' new tool addresses a critical pain point in healthcare administration: the time-sensitive nature of peer-to-peer reviews following payer denials. With nearly half of physicians citing lack of time as a barrier to appeals, and over 80% of formally appealed denials being overturned, the solution aims to enhance efficiency and accuracy in denial management. This launch is part of Xsolis' broader strategy to integrate generative AI across its Dragonfly platform, positioning the company as a leader in reducing administrative waste in healthcare.
What we're watching
- Adoption Pace
- The pace at which health systems integrate the GenAI Peer-to-Peer Clinical Synopsis into their workflows will determine its market penetration.
- Efficiency Gains
- Whether the 68% reduction in review time observed in the pilot can be replicated at scale across multiple health systems.
- Competitive Response
- How competitors in the healthcare AI space will react to Xsolis' latest generative AI capabilities.